Extracellularly, the administration of recombinant MANF protein affords neuroprotection in multiple disease conditions, including Parkinson’s disease (PD), ischemic stroke and retinal degeneration [13–16], although the transmembrane receptor that mediates such protective effects has not been clearly defined [17]. The gene discussed is MANF; the disease is ischemic stroke.